SchootsIG, PadhaniAR. Risk-adapted biopsy decision based on prostate magnetic resonance imaging and prostate-specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation. BJU Int, 2021; 127(2):175–178; doi: 10.1111/bju.15277
2.
WoźnickiP, WesthoffN, HuberT, et al.Multiparametric MRI for prostate cancer characterization: Combined use of Radiomics model with PI-RADS and clinical parameters. Cancers (Basel), 2020; 12(7):1767; doi: 10.3390/cancers12071767